<?xml version="1.0" encoding="UTF-8"?>
<ref id="B119-pharmaceuticals-13-00096">
 <label>119.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tran</surname>
    <given-names>D.H.</given-names>
   </name>
   <name>
    <surname>Sugamata</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Hirose</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Noguchi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sugawara</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ito</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kawachi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Akagawa</surname>
    <given-names>K.S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1) pdm09 virus infection by interfering with virus internalization process</article-title>
  <source>J. Antibiot.</source>
  <year>2019</year>
  <volume>72</volume>
  <fpage>759</fpage>
  <lpage>768</lpage>
  <pub-id pub-id-type="doi">10.1038/s41429-019-0204-x</pub-id>
  <pub-id pub-id-type="pmid">31300721</pub-id>
 </element-citation>
</ref>
